“Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in health”, Braz. J. Pharm. Sci., vol. 56, p. e17836 , Dec. 2020, doi: 10.1590/s2175-97902020000217836.